Newsstand Menu

Home / News / CSHL Stories and Media / LabDish Blog

CSHL Stories and Media archive for Tag: pancreatic/pancreas cancer

Turning off the immune system is hard. Turning it on against cancer is easier.

1/10/2018

How Professor Doug Fearon’s experiences with autoimmune disease patients contributed to the discovery of a new potential immunotherapy for cancer. Read the story »

Halfway around the world, a reunion of friends opens door to a cancer discovery

8/31/2017

After interviewing for a position in a pancreatic cancer lab at Cold Spring Harbor Laboratory, 7,000 miles from his hometown in South Korea, Chang-il. Read the story »

Long-sought mechanism of metastasis is discovered in pancreatic cancer

7/27/2017

An epigenetic factor reprograms gene enhancers, enabling cancer cells to “remember” an earlier developmental state and causing metastasis. Read the story »

Why is pancreatic cancer SO hard to treat? New discovery helps explain

5/16/2017

Discovery of distinct cell types helps explain why pancreatic cancer is so hard to treat. Watch the video »

CSHL to lead international team developing next-generation organoid cancer research

5/11/2017

CSHL awarded a research subcontract by Leidos Biomedical Research to lead Cancer Model Development Center for upper-gastrointestinal cancers. Read the story »

Mutations in “junk” DNA are tied to pancreatic cancer

5/8/2017

Mutations in the often-ignored gene-regulating parts of DNA are revealed to influence specific pathway pathologies in pancreatic cancer. Watch the video »

Newly discovered mutations impair key cell pathways in pancreatic cancer

5/8/2017

Researchers have found important new clues to the development of pancreatic cancer. Read the story »

Discovery of distinct cell subtypes around tumors helps explain why pancreatic cancer is so hard to treat

2/23/2017

Researchers finds that stroma,“wound”-like tissue that surrounds the tumors, helps explain why pancreatic cancer is so resistant to treatment. Read the story »

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

12/9/2016

Truncated p53 proteins, presumed unimportant, now point to new drug targets for some of "the hardest cancers" Read the story »

Base Pairs Episode 6: When antioxidants are pro-cancer

11/15/2016

Recent research on antioxidant levels in the cells of pancreatic cancer patients is homing in on a new, safer avenue for treatment. Listen to the podcast »

When antioxidants are pro-cancer

11/15/2016

For Pancreatic Cancer Awareness Month, Base Pairs looks at the science of antioxidants and cancer. Read the story »

Pancreas and colon tumors reprogram the liver, causing wasting and short-circuiting body’s immune response

11/8/2016

Research reveals a mechanism that causes wasting in cancer and tests a way to reverse it. Read the story »

What’s the connection between antioxidants and cancer?

10/14/2016

David Tuveson discusses the relationship between antioxidants and cancer, and how the former doesn't necessarily prevent the latter. Read the story »

Novel drug therapy kills pancreatic cancer cells by reducing levels of antioxidants

7/29/2016

Reducing levels of antioxidants in pancreatic cancer cells can help kill them. Watch the video »

Novel drug therapy kills pancreatic cancer cells by reducing levels of antioxidants

7/28/2016

Researchers demonstrate that in the specific context of pancreatic cells leading to cancer, raisin antioxidant levels should not be raised. Read the story »

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

CSHL Stories and Media archive for Tag: pancreatic/pancreas cancer

Turning off the immune system is hard. Turning it on against cancer is easier.

Halfway around the world, a reunion of friends opens door to a cancer discovery

Long-sought mechanism of metastasis is discovered in pancreatic cancer

Why is pancreatic cancer SO hard to treat? New discovery helps explain

CSHL to lead international team developing next-generation organoid cancer research

Mutations in “junk” DNA are tied to pancreatic cancer

Newly discovered mutations impair key cell pathways in pancreatic cancer

Discovery of distinct cell subtypes around tumors helps explain why pancreatic cancer is so hard to treat

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

Base Pairs Episode 6: When antioxidants are pro-cancer

When antioxidants are pro-cancer

Pancreas and colon tumors reprogram the liver, causing wasting and short-circuiting body’s immune response

What’s the connection between antioxidants and cancer?

Novel drug therapy kills pancreatic cancer cells by reducing levels of antioxidants

Novel drug therapy kills pancreatic cancer cells by reducing levels of antioxidants

Contact

Connect with CSHL